This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
April 24, 2017
Capio acquires a Swedish eye specialist clinic in Stockholm
April 20, 2017
Onxeo receives the EnterNext Tech 40 Label
April 20, 2017
Cash position and update on clinical developments for Q1 2017
April 20, 2017
GenSight Biologics to Present GS010 at the 2017 Annual Meeting of the American Association of Neurology
April 20, 2017
Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform
April 19, 2017
Targovax ASA: Invitation to first quarter 2017 results presentation Tuesday 25 April
April 19, 2017
GenSight Biologics to Attend Upcoming Investor Conferences
April 18, 2017
Cerenis Therapeutics announces the initiation of the Phase 1 clinical study with CER-209 in NAFLD and NASH
April 11, 2017
BONESUPPORT™ appoints Michael Diefenbeck as Chief Medical Officer
April 06, 2017
Report from Orexo AB´s annual general meeting, April 6 2017